Commentary
Journal of Commercial Biotechnology advance online publication 22 September 2009; doi: 10.1057/jcb.2009.27
Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewskia and Elizabeth A Jexb
- aOffice of Policy Planning, Federal Trade Commission, Washington DC, USA
- bFTC Office of Policy Planning, Washington DC, USA
